Bailey; Murray D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bailey; Murray D..The latest application filed is for "inhibitors of human immunodeficiency virus replication".

Company Profile

0.27.20

Bailey; Murray D. - Laval CA
Bailey; Murray D. - Pierrefonds N/A CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Human Immunodeficiency Virus Replication App 20140296228 - Tsantrizos; Youla S. ; et al.	2014-10-02
Inhibitors of human immunodeficiency virus replication Grant 8,841,331 - Yoakim , et al. September 23, 2	2014-09-23
Inhibitors of human immunodeficiency virus replication Grant 8,710,230 - Tsantrizos , et al. April 29, 2	2014-04-29
Inhibitors Of Human Immunodeficiency Virus Replication App 20130203747 - Yoakim; Christiane ; et al.	2013-08-08
Inhibitors Of Human Immunodeficiency Virus Replication App 20130197231 - Tsantrizos; Youla S. ; et al.	2013-08-01
Inhibitors Of Human Immunodeficiency Virus Replication App 20130190491 - Tsantrizos; Youla S. ; et al.	2013-07-25
Inhibitors of human immunodeficiency virus replication Grant 8,461,180 - Tsantrizos , et al. June 11, 2	2013-06-11
Inhibitors of human immunodeficiency virus replication Grant 8,377,960 - Tsantrizos , et al. February 19, 2	2013-02-19
Inhibitors of human immunodeficiency virus replication Grant 8,354,429 - Tsantrizos , et al. January 15, 2	2013-01-15
Inhibitors Of Human Immunodeficiency Virus Replication App 20110118249 - Tsantrizos; Youla S. ; et al.	2011-05-19
Hepatitis C inhibitor tri-peptides Grant RE42,164 - Llinas-Brunet , et al. February 22, 2	2011-02-22
Inhibitors Of Human Immunodeficiency Virus Replication App 20110028464 - Tsantrizos; Youla S. ; et al.	2011-02-03
Inhibitors Of Human Immunodeficiency Virus Replication App 20100311735 - Tsantrizos; Youla S. ; et al.	2010-12-09
Hepatitis C inhibitor tri-peptides Grant RE41,894 - Llinas-Brunet , et al. October 26, 2	2010-10-26
Hepatitis C inhibitor tri-peptides Grant RE41,356 - Llinas-Brunet , et al. May 25, 2	2010-05-25
Hepatitis C inhibitor peptide analogs Grant 7,705,146 - Bailey , et al. April 27, 2	2010-04-27
Hepatitis C inhibitor peptide analogs Grant 7,696,242 - Bailey , et al. April 13, 2	2010-04-13
Inhibitors of Hepatitis C NS3 Protease App 20100087382 - Bailey; Murray D. ; et al.	2010-04-08
Hepatitis C Inhibitor Dipeptide Analogs App 20090156822 - BAILEY; Murray D. ; et al.	2009-06-18
Hepatitis C inhibitor dipeptide analogs Grant 7,511,157 - Bailey , et al. March 31, 2	2009-03-31
Macrocyclic peptides active against the hepatitis C virus Grant 7,504,378 - Llinas-Brunet , et al. March 17, 2	2009-03-17
Hepatitis C inhibitor tri-peptides Grant RE40,525 - Llinas-Brunet , et al. September 30, 2	2008-09-30
Hepatitis C Inhibitor Peptide Analogs App 20080200497 - Bailey; Murray D. ; et al.	2008-08-21
Hepatitis c inhibitor peptide analogs App 20060258868 - Bailey; Murray D. ; et al.	2006-11-16
Hepatitis C inhibitor tri-peptides Grant 7,091,184 - Llinas-Brunet , et al. August 15, 2	2006-08-15
Macrocyclic peptides active against the hepatitis C virus App 20060089300 - Llinas-Brunet; Montse ; et al.	2006-04-27
Hepatitis C inhibitor dipeptide analogs App 20060046965 - Bailey; Murray D. ; et al.	2006-03-02
Hepatitis C inhibitor peptide analogs App 20060019905 - Bailey; Murray D. ; et al.	2006-01-26
Hepatitis C inhibitor peptide analogs Grant 6,908,901 - Bailey , et al. June 21, 2	2005-06-21
Macrocyclic peptides active against the hepatitis C virus App 20050075279 - Llinas-Brunet, Montse ; et al.	2005-04-07
Hepatitis C inhibitor peptide analogs App 20040224900 - Bailey, Murray D. ; et al.	2004-11-11
Hepatitis C inhibitor peptides Grant 6,767,991 - Llinas-Brunet , et al. July 27, 2	2004-07-27
Hepatitis C inhibitor tri-peptides App 20030191067 - Llinas-Brunet, Montse ; et al.	2003-10-09
Hepatitis C inhibitor tri-peptides App 20030186895 - Llinas-Brunet, Montse ; et al.	2003-10-02
Hepatitis C inhibitor tri-peptides Grant 6,534,523 - Llinas-Brunet , et al. March 18, 2	2003-03-18
Hepatitis C inhibitor tri-peptides Grant 6,420,380 - Llinas-Brunet , et al. July 16, 2	2002-07-16
Hepatitis C inhibitor tri-peptides Grant 6,410,531 - Llinas-Brunet , et al. June 25, 2	2002-06-25
Hepatitis C inhibitor tri-peptides App 20020037998 - Llinas-Brunet, Montse ; et al.	2002-03-28
Hepatitis C inhibitor tri-peptides App 20020016442 - Llinas-brunet, Montse ; et al.	2002-02-07
Hepatitis C inhibitor tri-peptides Grant 6,329,379 - Llinas-Brunet , et al. December 11, 2	2001-12-11
Hepatitis C inhibitor tri-pepitides Grant 6,329,417 - Llinas-Brunet , et al. December 11, 2	2001-12-11
Hepatitis C inhibitor tri-peptides Grant 6,323,180 - Llinas-Brunet , et al. November 27, 2	2001-11-27
Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester Grant 6,268,207 - Bailey July 31, 2	2001-07-31
Hepatitis C inhibitor peptide analogues Grant 6,143,715 - Llinas-Brunet , et al. November 7, 2	2000-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.